ArticleNeurology and therapy2021

Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR.

Aaron Yarlas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.